Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. BMY's current price target is $ Learn why top analysts are making this stock forecast for Bristol-Myers Squibb at MarketBeat. Get Bristol-Myers Squibb Co (BMY:NYSE) real-time stock quotes, news, price and financial information from CNBC. Bristol-Myers Squibb Company (BMY) stock forecast and price target · Recommendation Rating · Large Cap US Pick List - August Out of 7 analysts, 0 (0%) are recommending BMY as a Strong Buy, 0 (0%) are recommending BMY as a Buy, 6 (%) are recommending BMY as a Hold, 0 (0%) are.
See the latest Bristol-Myers Squibb Co stock price (BMY:XNYS), related news, valuation, dividends and more to help you make your investing decisions. Bristol-Myers Squibb's revenue is forecast to decline at % per annum while its annual earnings are expected to grow at % per year. EPS is expected to. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. BMY will report earnings. Stock analysis for Bristol-Myers Squibb Co (BMY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company. According to 17 analysts, the average rating for BMY stock is "Hold." The month stock price forecast Bristol-Myers Squibb: A Better Earnings Outlook. According to analysts, BMY price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. View Bristol-Myers Squibb Company BMY stock quote prices, financial information, real-time forecasts, and company news from CNN. The Bristol-Myers Squibb Company stock price today is What Is the Stock Symbol for Bristol-Myers Squibb Company? The stock ticker symbol for Bristol-. Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. BMY updated stock price target summary. The 16 analysts with month price forecasts for BMY stock have an average target of , with a low estimate of 42 and a high estimate of The average. Bristol-Myers Squibb (BMY) stock price prediction is USD. The Bristol-Myers Squibb stock forecast is USD for September.
The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the. Analyst Price Targets ; Low ; Average ; Current ; High. Bristol-Myers Squibb Stock Forecast · Over the next 52 weeks, Bristol-Myers Squibb has on average historically risen by % based on the past 52 years of stock. A high-level overview of Bristol-Myers Squibb Company (BMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. The average price target is $ with a high estimate of $62 and a low estimate of $ Sign in to your SmartPortfolio to see more analyst recommendations. According to the current price, Bristol-Myers Squibb is % away from the week high. What are analysts forecasts for Bristol-Myers Squibb stock? The Stock Price Target. High, $ Low, $ Average, $ Current Price, $ BMY will report FY earnings on 02/06/ Yearly Estimates. Bristol-Myers Squibb (BMY) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Bristol-Myers Squibb stock would need to gain 1,% to reach $1, According to our Bristol-Myers Squibb stock forecast, the price of Bristol-Myers Squibb.
Bristol-Myers Squibb · Open. · Previous Close. · High. · Low. · 52 Week High. · 52 Week Low. · Beta. · TTM EPS Trend. (-. The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing price of $ The current price of BMY is USD — it has decreased by −% in the past 24 hours. Watch Bristol-Myers Squibb Company stock price performance more closely. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products.
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. Jefferies Adjusts Price Target on Bristol-Myers Squibb to $51 From $49, Maintains Hold Rating · Barclays Adjusts Bristol-Myers Squibb Price Target to $42 From. Analyst. Target Price. · 21 analysts ; Earnings. EPS Forecast. Down. Next quarter ; Investor. New Investor. Andra AP Fonden. +% Portfolio. Get the latest Bristol-Myers Squibb Company (BMY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Best Stocks To Watch Out For | Org Chart Roles And Responsibilities